<!DOCTYPE html>
<!--[if lt IE 9]><html class="no-js lt-ie9" lang="en" dir="ltr"><![endif]-->
<!--[if gt IE 8]><!--><html class="no-js" lang="en" dir="ltr"><!--<![endif]-->
	<head>
		<meta charset="utf-8">
		<!-- Web Experience Toolkit (WET) / Boîte à outils de l'expérience Web (BOEW) wet-boew.github.io/wet-boew/License-en.html / wet-boew.github.io/wet-boew/Licence-fr.html -->
		<title>COVID-19 Vaccine and drug progress tracker - Canada.ca</title>
		<meta content="width=device-width,initial-scale=1" name="viewport">
		<!-- Meta data -->
		<!-- Meta data-->
		<!-- Load closure template scripts -->
		<script type="text/javascript" src="https://www.canada.ca/etc/designs/canada/cdts/gcweb/v4_0_30/cdts/compiled/soyutils.js"></script>
		<script type="text/javascript" src="https://www.canada.ca/etc/designs/canada/cdts/gcweb/v4_0_30/cdts/compiled/wet-en.js"></script>
		<link href="https://test.canada.ca/covid-19-guidance/proto/css/alpha-beta-banner.css" rel="stylesheet">

		<!-- Write closure template -->
		<script type="text/javascript">
			document.write(wet.builder.refTop({
			}));
		</script>
	</head>
	
	<body vocab="http://schema.org/" typeof="WebPage">
		<div id="def-top">
		</div>
		<!-- Write closure template -->
		<script type="text/javascript">
			var defTop = document.getElementById("def-top");
			defTop.outerHTML = wet.builder.top({
				lngLinks: [{
					lang: "fr",
					href: "travel-advice-fr.html",
					text: "Français"
				}],
				breadcrumbs: [{
					title: "Home",
					href: "https://www.canada.ca/en.html"
				},{
					title: "Health",
					href: "https://www.canada.ca/en/services/health.html"
				},{
					title: "Diseases and conditions",
					href: "https://www.canada.ca/en/public-health/services/diseases.html"
				},{
					title: "Coronavirus (COVID-19)",
					href: "landing.html"
				}],
				search: true,
				siteMenu: true,
				showPreContent: true
			});
</script>
<link rel="stylesheet" href="https://use.fontawesome.com/releases/v5.8.1/css/all.css" integrity="sha384-50oBUHEmvpQ+1lW4y57PTFmhCaXp0ML5d60M1M7uH2+nqUivzIebhndOJK28anvf" crossorigin="anonymous"/>

<main role="main" property="mainContentOfPage" class="container">

	<h1 property="name" id="wb-cont" dir="ltr">Drugs and vaccines for COVID-19: Progress tracker <br> </h1>
		
	<div class="row">

		<!--<<div class="gc-stp-stp">
			<div class="row">
				<ul class="toc lst-spcd col-md-12">
					<li class="col-md-4 col-sm-6"><a class="list-group-item active" href="">Progress</a></li>
					<li class="col-md-4 col-sm-6"><a class="list-group-item" href="./drugs-vaccines-authorized-clinical-trials.html">List of authorized clinical trials</a></li>
					<li class="col-md-4 col-sm-6"><a class="list-group-item" href="./drugs-vaccines-regulatory-response.html">Regulatory response</a></li>
					<li class="col-md-4 col-sm-6"><a class="list-group-item" href="./drugs-vaccines-conducting-clinical-trials.html">Conducting a COVID-19 clinical trial</a></li>
				</ul>
			</div>
		</div>
		<-->
		<div class="col-md-6 pull-right mrgn-tp-lg panel panel-default">
			<p class="mrgn-tp-md"><span class="text-info h2">77%</span> of Canadians report they are likely to get a <span class="no-break"></span>COVID-19 vaccination when it's available.</p>
			<p><strong>Source:</strong> <a href="https://www150.statcan.gc.ca/n1/pub/45-28-0001/2020001/article/00073-eng.htm">Statistics Canada - Canadians' willingness to get a COVID-19 vaccine</a></p>
		</div>
		<div class="col-md-6 pull-left">
			<h2>On this page</h2>
			<ul>		 
				<li><a href="#a1">Vaccines and treatments approved for use in Canada</a></li>
				<li><a href="#a2">Securing doses of potential vaccine candidates and treatments</a></li>
				<li><a href="#a3">Making sure vaccines and treatments are safe</a></li>
				<li><a href="#a4">Government funding for vaccine and treatments research</a></li>
				<li><a href="#a5">Vaccines are safe to use and crucial to protecting Canadians</a></li>
			</ul>
		</div>

	</div>
		
		<h2 id="a1">Vaccines and treatments approved for use in Canada</h2>

		<section class="well-sm">
			<div class="container-fluid mrgn-tp-md mrgn-bttm-md">
				<div class="row mrgn-bttm-md">
					<div class="col-xs-12">
						
						<!-- <div class="pstn-lft-xs pstn-tp-xs"><span class="fa-stack fa-fw mrgn-lft-sm text-info"> <span class="fas fa-square fa-stack-2x fa-inverse"></span> span class="fas fa-tablets fa-stack-2x"></span</span></div> -->
						<p>Health Canada scientific reviewers evaluate data to assess the potential benefits and risks of a drug or vaccine. They also review the information that will be provided to health care practitioners and consumers about the product. After the review, we may authorize the drug or vaccine for sale in Canada only if the benefits of the product outweigh the potential risks.</p>
						<p>Supported by: <a href="https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/authorization.html">Health Canada - Drug and vaccine authorizations for COVID-19</a></p>
						<h3 class="pull-left mrgn-tp-0 mrgn-lft-sm text-info" id="confirm-registration">Drug treatments approved for the treatment of COVID-19</h3>
						<div class="clearfix"></div>
							<div class="mrgn-lft-lg table-responsive">
								<table class="table table-striped table-hover table-responsive small">
									<thead>
									<tr>
										<th scope="col">Drug </th>
										<th scope="col">Brand name</th>
										<th scope="col">Starting date</th>
										<th scope="col">Conditions</th>
									</tr>
									</thead>
									<tbody>
										<tr>
											<td>Remdesivir</a></td>
											<td>Veklury</td>
											<td><span class="label label-success">July 28,2020</span></td>
											<td><a href="https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2020/73621a-eng.php">Pneumonia with severe symptoms</a></td>
										</tr>			  
									</tbody>
								</table>		
							</div>
					</div>
				</div>
					
				<div class="row mrgn-bttm-md">
					<div class="col-xs-12">
						
						<!-- <div class="pstn-lft-xs pstn-tp-xs"><span class="fa-stack fa-fw mrgn-lft-sm text-info"> <span class="fas fa-square fa-stack-2x fa-inverse"></span> <span class="fas fa-syringe fa-stack-2x"></span></span></div> -->
						<h3 class="pull-left mrgn-tp-0 mrgn-lft-sm text-info" id="confirm-registration">A COVID-19 vaccine is not yet approved for use in Canada</h3>
						<div class="clearfix"></div>
						<div class="brdr-lft mrgn-lft-md mrgn-tp-sm"></div>
							<div class="mrgn-lft-lg">
							</div>
						</div>
					</div>
				</div>
			</div>
		</section>

		<section class="well well-sm brdr-0 mrgn-bttm-0">
			<div class="container-fluid mrgn-tp-md mrgn-bttm-sm">
				<h2 id="a2" class="mrgn-tp-0">Securing potential vaccines and supplies</h2>
				<p>The Government of Canada is securing millions of doses of potential vaccine candidates.  All potential vaccines will require Health Canada regulatory approval prior to being used to vaccinate Canadians.</p>
				<p>Supported by: <a href="https://www.tpsgc-pwgsc.gc.ca/comm/index-eng.html">Public Services and Procurement Canada</a>, <a href="https://www.ic.gc.ca/eic/site/icgc.nsf/eng/home">Innovation, Science and Industry</a>, and <a href="https://nrc.canada.ca/en/corporate/covid-19-vaccine-task-force">the COVID-19 Vaccine Task Force </a></p>
				<div class="row mrgn-bttm-md">
					<div class="col-xs-12">
						<div class="brdr-lft mrgn-lft-md mrgn-tp-sm">
							<div class="pstn-lft-xs pstn-tp-xs"><span class="fa-stack fa-fw mrgn-lft-sm text-info"> <span class="fas fa-square fa-stack-2x fa-inverse"></span> <span class="fas fa-shipping-fast fa-stack-2x"></span></span></div>
							<h3 class="pull-left mrgn-tp-0 mrgn-lft-lg h3 text-info" id="confirm-registration">Agreements for potential vaccines and human trial status</h3>
							<div class="clearfix"></div>
							<div class="mrgn-lft-lg table-responsive">
								<table class="table table-striped table-hover table-responsive small">
									<thead>
									<tr>
										<th scope="col">Supplier</th>
										<th scope="col">Latest status</th>
										<th scope="col">Human trials</th>
										<th scope="col">Vaccine at Clinicaltrials.gov</th>
										<th scope="col">Approvals in Canada</th>
									</tr>
									</thead>
									<tbody>
										<tr>
											<td>Johnson and Johnson</td>					
											<td><a href="https://pm.gc.ca/en/news/news-releases/2020/08/31/new-measures-ensure-supply-future-vaccines-and-therapies-against">Agreement</a></td>
											<td>Phases:<span class="label label-info">1</span><span class="label label-info">2</span><span class="label label-info">3</span></td>										
											<td><a href="https://clinicaltrials.gov/ct2/results?cond=&term=Ad26.COV2.S">Ad26.COV2.S</a></td>
											<td><span class="label label-default">None</span></td>	  	  	
										</tr>										<tr>
											<td>Moderna</td>
											<td><a href="https://www.canada.ca/en/innovation-science-economic-development/news/2020/08/government-of-canada-announces-major-steps-in-treating-and-preventing-covid-19-through-vaccines-and-therapies.html">Agreement</a></td>
											<td>Phases:<span class="label label-info">1</span><span class="label label-info">2</span><span class="label label-info">3</span></td>										
											<td><a href="https://clinicaltrials.gov/ct2/results?cond=&term=mRNA-1273">mRNA-1273</a></td>
											<td><span class="label label-default">None</span></td>
										</tr>	
										<tr>
											<td>Novavax</td>					
											<td><a href="https://pm.gc.ca/en/news/news-releases/2020/08/31/new-measures-ensure-supply-future-vaccines-and-therapies-against">Agreement</a></td>
											<td>Phases:<span class="label label-info">1</span><span class="label label-info">2</span></td>											
											<td><a href="https://clinicaltrials.gov/ct2/results?cond=&term=NVX-CoV2373">NVX-CoV2373</a></td>
											<td><span class="label label-default">None</span></td>	  	
										</tr>		  
										<tr>
											<td>Pfizer</td>					
											<td><a href="https://www.canada.ca/en/innovation-science-economic-development/news/2020/08/government-of-canada-announces-major-steps-in-treating-and-preventing-covid-19-through-vaccines-and-therapies.html">Agreement</a></td>
											<td>Phases:<span class="label label-info">1</span><span class="label label-info">2</span><span class="label label-info">3</span></td>										
											<td><a href="https://clinicaltrials.gov/ct2/results?cond=&term=BNT162">BNT162</a></td>
											<td><span class="label label-default">None</span></td>
										</tr>
									</tbody>
								</table>	
							</div>
						</div>
					</div>
				</div>

				<h3>Planning for manufacturing and immunization</h3>
				<p>Plans and purchases are being made to efficiently, effectively and equitably produce, distribute and administer an eventual COVID-19 vaccine. These include: </p>
				<ul>
					<li><a href="https://nrc.canada.ca/en/research-development/research-collaboration/increasing-biomanufacturing-capacity">Accelerate production and testing of vaccine candidates</a> by the National Research Council </li>			
					<li>Agreements to purchase syringes, alcohol swabs and other immunization supplies</li>
					<li>Funding and agreements for final manufacturing and packing stages of vaccine production in Canada</li>
					<li><a href="https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/research-priorities-covid-19-vaccines.html#toc8">Assess feasibility and equity</a> of options for storage and handling and administration  </li>
					</ul>
			</div>
		</section>

		<section class="well-sm">
			<div class="container-fluid mrgn-tp-md mrgn-bttm-md">
				<h2 id="a3">Making sure vaccines and treatments are safe</h2>
				<p>All drugs, including vaccines, must meet the regulatory requirements for safety, efficacy and quality before they can be sold in Canada. Phase 1, 2 and 3 clinical human trials ensure that potential COVID-19 vaccines are safe for Canadians and effectively prevent infections.</p> 
				<p>Supported by: <a href="https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/conducting-clinical-trial.html">Health Canada - Conducting COVID-19 clinical trials</a></p>

				<!-- <div class="row mrgn-bttm-md"> -->
					<!-- <div class="col-xs-12"> -->
						<!-- <div class="brdr-lft mrgn-lft-md mrgn-tp-sm"></div> -->
							<!-- <div class="pstn-lft-xs pstn-tp-xs"><span class="fa-stack fa-fw mrgn-lft-sm text-info"> <span class="fas fa-square fa-stack-2x fa-inverse"></span> <span class="fas fa-first-aid fa-stack-2x"></span></div> -->
							<h3 class="text-info" id="confirm-registration">Vaccine clinical trials with Canadian participants</h3>
							<div class="table-responsive">
								<table class="table table-striped table-hover table-responsive small">
									<thead>
								<tr>
									<th scope="col">Lead</th>
									<th scope="col">Vaccine</th>
									<th scope="col">Support</th>
									<th scope="col" class="col-sm-1">Phase 1</th>
									<th scope="col" class="col-sm-1">Phase&nbsp;2</th>
									<th scope="col" class="col-sm-1">Phase 3</th>
									<th scope="col" class="col-sm-1">Approval</th>
								</tr>
								</thead>
								<tbody>
								<tr>
									<td>Medicago Inc.</td>
									<td>CoVLP</td>
									<td><a href="https://pm.gc.ca/en/news/news-releases/2020/03/23/canadas-plan-mobilize-science-fight-covid-19">Strategic Innovation Fund</a></td>
									<td><a href="https://clinicaltrials.gov/ct2/show/NCT04450004">#NCT04450004</a><span class="label label-success">In progress</span></td>
									<td></td>
									<td></td>
									<td></td>
								</tr>
								<tr>
									<td>CanSino Biologics Inc.</td>
									<td>Ad5-nCoV</td>
									<td></td>
									<td><a href="https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-clinical-trials/list-authorized-trials.html">#239283 </a><span class="label label-info"> Authorized</span></td>
									<td></td>
									<td></td>
									<td></td>
								</tr>
								<tr>
									<td>Canadian Cancer Trials Group</td>
									<td>IMM-101</td>
									<td>Cancer patients</td>
									<td></td>
									<td></td>
									<td><a href="https://clinicaltrials.gov/ct2/show/NCT04442048">#NCT04442048 </a><span class="label label-success"> In progress</span></td>
									<td></td>
								</tr>
								<tr>
									<td>Princess Margaret Cancer Centre</td>
									<td>BCG VPM1002</td>
									<td>Cancer patients</td>
									<td><span class="label label-success"> 2009 </span></td>
									<td><span class="label label-success"> 2012 </span></td>
									<td><a href="https://clinicaltrials.gov/ct2/show/NCT04439045">#NCT04439045</a><span class="label label-success"> In progress </span></td>
									<td></td>
								</tr>
								</tbody>
							</table>
							</div>
						
				
				<p>Canada's National Advisory Committee on Immunization (NACI) is providing rapid guidance on clinical trial research priorities for COVID-19 vaccine candidates.</p>
				<ul>
					<li><a href="https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci.html">National Advisory Committee on Immunization</a></li>
				</ul>

				<h3 class="text-info">Clinical trials of drugs in Canada </h2>
				<p>Drugs and treatment options in Canadian human trials and research studies include: </p>
				<ul>
					<li>antiviral drugs</li>
					<li>anti-malarial drugs</li>
					<li>monoclonal antibodies and other drugs that address inflammation</li>
					<li><a href="https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2020/72957a-eng.php">convalescent plasma</a> collected from patients who have recovered from COVID-19</li>
					<li>medical gases</li>
				</ul>
				<p>For a complete list, see Health Canada's <a href="./drugs-vaccines-authorized-clinical-trials.html">authorized COVID-19 clinical trials</a></p> 
			</div>
		</section>

		<section class="well well-sm brdr-0 mrgn-bttm-0">
			<div class="container-fluid mrgn-tp-md mrgn-bttm-sm">
				<h2 id="a4" class="mrgn-tp-0">Government funding for vaccine and treatment research</h3>
				<p>Funding from Innovation Canada for the most promising options for safe, effective vaccines is being made available to vaccine and bio-manufacturing applications from domestic candidates reviewed by the COVID-19 Task Force.</p>

			
				<h3 class="text-info" id="confirm-registration">Funding early stage vaccines in Canada</h3>
				<div class="table-responsive">
					<table class="table table-striped table-hover table-responsive small">
						<thead>
							<tr>
							<th scope="col">Vaccine developer</th>
							<th scope="col">Vaccine</th>
							<th scope="col">Funding announcement</th>
							</tr>
						</thead>
						<tbody>
							<tr>
								<td>VIDO-Intervac</a></td>
								<td>Not named</td>
								<td><a href="https://pm.gc.ca/en/news/news-releases/2020/04/23/prime-minister-announces-new-support-covid-19-medical-research-and">Multiple sources</sa></td>
							</tr>			  
							<tr>
								<td>Variation Biotechnologies Inc.</a></td>
								<td>VBI-2900</td>
								<td><a href="https://www.canada.ca/en/innovation-science-economic-development/news/2020/08/government-of-canada-announces-major-steps-in-treating-and-preventing-covid-19-through-vaccines-and-therapies.html">Strategic Innovation Fund</sa></td>
							</tr>			  
							<tr>
								<td>IMV Inc.</td>					
								<td>BNT162</td>
								<td><a href="https://www.canada.ca/en/innovation-science-economic-development/news/2020/08/government-of-canada-announces-major-steps-in-treating-and-preventing-covid-19-through-vaccines-and-therapies.html">Multiple sources</a></td>
								</tr>
						</tbody>
					</table>		
				</div>


				<div class="row mrgn-bttm-md">
					<div class="col-xs-12">				
						<h3 class="pull-left mrgn-tp-0 mrgn-lft-sm h3 text-info" id="confirm-registration">COVID-19 basic vaccine research funding</h3>
						<div class="clearfix"></div>
							<div class="table-responsive">

								<p>The national medical research strategy to fight COVID-19 includes support for basic genetic and vaccine research and immunization strategies.    </p>
								<table class="table table-striped table-hover table-responsive small">
									<thead>
									<tr>
										<th scope="col">Research activity</th>
										<th scope="col">Announcement date</th>
										<th scope="col">Vaccine projects</th>
										<th scope="col">Funding</th>
									</tr>
									</thead>
									<tbody>
										<tr>
											<td>Canadian Institutes of Health Research(CIHR)</td>
											<td><a href="https://cihr-irsc.gc.ca/e/51908.html">February 2020 competition</a></td>
											<td><a href="https://webapps.cihr-irsc.gc.ca/decisions/p/main.html?lang=en#fq={!tag=competitioncd}competitioncd%3A202002OV5&sort=namesort%20asc&start=0&rows=20">6 projects</a></td>
											<td><span class="label label-success">$5.1 million</span></td>
										</tr>			  
										<tr>
											<td>Canadian Institutes of Health Research(CIHR)</td>
											<td><a href="https://cihr-irsc.gc.ca/e/52013.html">May 2020 competition</a></td>
											<td><a href="https://webapps.cihr-irsc.gc.ca/decisions/p/main.html?lang=en#fq={!tag=competitioncd}competitioncd%3A202005VR1&sort=namesort%20asc&start=0&rows=20">8 projects</a></td>
											<td><span class="label label-success">$11.7 million</span></td>
										</tr>
										<tr>
										<td>Canadian Immunization Research Network</td>
										<td>April 2020</td>
										<td><a href="https://pm.gc.ca/en/news/news-releases/2020/04/23/prime-minister-announces-new-support-covid-19-medical-research-and">trials and monitoring</a></td>
										<td><span class="label label-success">$15.3 million</span></td>
										</tr>
									</tbody>
								</table>	
							
								<h3 class="pull-left mrgn-tp-0 mrgn-lft-sm h3 text-info" id="drug">COVID-19 drug and therapeutic research funding</h3>				
								<table class="table table-striped table-hover table-responsive small">
									<thead>
									<tr>
										<th scope="col">Research activity</th>
										<th scope="col">Announcement date</th>
										<th scope="col">Projects</th>
										<th scope="col">Funding</th>
									</tr>
									</thead>
									<tbody>
										<tr>
											<td>Canadian Institutes of Health Research(CIHR)</td>
											<td><a href="https://cihr-irsc.gc.ca/e/51908.html">February 2020 - Therapeutics</a></td>
											<td>18 projects</td>
											<td><span class="label label-success">$11.5 million</span></td>
										</tr>			  
										<tr>
											<td>Canadian Institutes of Health Research(CIHR)</td>
											<td><a href="https://cihr-irsc.gc.ca/e/52013.html">May 2020 - Therapeutics</a></td>
											<td>30 projects</td>
											<td><span class="label label-success">$35.1 million</span></td>
										</tr>
										</tr>
										<tr>
											<td>AbCellera</td>
											<td>May 3, 2020</td>
											<td><a href="https://www.canada.ca/en/innovation-science-economic-development/news/2020/05/minister-bains-announces-investment-in-antibody-discovery-technology-to-help-treat-covid-19.html">Antibody drugs</a></td>
											<td><span class="label label-success">$175.6 million</span></td>
										</tr>
										</tr>
									</tbody>
								</table>
							</div>
					</div>
				</div>
			</div>
		</section>
		
		<section class="well-sm">
			<div class="container-fluid mrgn-tp-md mrgn-bttm-md">
				<h2 id="a5">Vaccines are safe to use and crucial to protecting Canadians</h2>
				<p>The Government of Canada has strict regulations and testing requirements to ensure that approved vaccines are safe to use. </p>
				<p>Drugs, including vaccines must meet the regulatory requirements for safety, efficacy and quality before they can be sold in Canada.</p>
				<ul>
					<li><a href="https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/activities/fact-sheets/regulation-vaccines-human-canada.html">How the Government of Canada ensures vaccines are safe for use</a></li>
					<li><a href="http://www.icmra.info/drupal/strategicinitiatives/vaccines/statement_general_public">International statement about confidence in vaccines</a></li>
				</ul>
				<h3>Working with international partners to ensure vaccines are safe and widely adopted</h3>
				<p>Canada is working with <a href="https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/engaging-international-partners.html">international partners</a> on a coordinated and well-aligned approach to this global pandemic. This ensures that health products are safe, effective and quickly available to Canadians. Collaboration also helps advance the development of diagnostics, treatments and vaccines that will save lives and protect the health and safety of people everywhere. </p>
				<ul>
					<li>Canada has committed to <a href="https://www.canada.ca/en/global-affairs/news/2020/05/minister-gould-announces-funding-for-global-vaccinations.html">funding global vaccinations for COVID-19</a></li>
				</ul>
			</div>
		</div>

  <div id="def-preFooter">
</div>
<!-- Write closure template -->
<script type="text/javascript">
	var defPreFooter = document.getElementById("def-preFooter");
	defPreFooter.outerHTML = wet.builder.preFooter({
		dateModified: "2020-03-13",
		showPostContent: true,
		showFeedback: true,
		showShare: true
	});
</script>
		</main>
		<div id="def-footer">

		</div>
		<!-- Write closure template -->
		<script type="text/javascript">
			var defFooter = document.getElementById("def-footer");
			defFooter.outerHTML = wet.builder.footer({
				showFooter: true,
				showFeatures: true
			});
		</script>
		<!-- Write closure template -->
				<script type="text/javascript">
			document.write(wet.builder.refFooter({
			}));
		</script>
		<script src="https://test.canada.ca/covid-19-guidance/proto/js/contact-link-swap.js"></script>
		<script src="https://test.canada.ca/covid-19-guidance/proto/js/alpha-banner.js"></script>
	</body>
</html>
